|
Volumn 365, Issue 26, 2011, Pages 2536-2538
|
Diabetic stem-cell "mobilopathy"
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHEMOKINE RECEPTOR CXCR4;
GRANULOCYTE COLONY STIMULATING FACTOR;
NERVE CELL ADHESION MOLECULE;
NESTIN;
PLERIXAFOR;
STROMAL CELL DERIVED FACTOR 1;
VASCULAR CELL ADHESION MOLECULE 1;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
ARTICLE;
CD34 SELECTION;
CELL TRANSPORT;
CELLULAR DISTRIBUTION;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
DOWN REGULATION;
DRUG MECHANISM;
HEMATOPOIETIC STEM CELL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
IMMOBILIZED CELL;
LYMPHOMA;
MICROENVIRONMENT;
MOBILOPATHY;
MYELOMA;
NONHUMAN;
OSTEOBLAST;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RISK REDUCTION;
STEM CELL MOBILIZATION;
ANIMAL;
HUMAN;
METHODOLOGY;
MOUSE;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
ANIMALS;
CHEMOKINE CXCL12;
DIABETES MELLITUS;
GRANULOCYTE COLONY-STIMULATING FACTOR;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HEMATOPOIETIC STEM CELL MOBILIZATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMATOPOIETIC STEM CELLS;
HUMANS;
MICE;
|
EID: 84855412101
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMcibr1112347 Document Type: Article |
Times cited : (80)
|
References (5)
|